Subscribe to RSS
DOI: 10.1055/s-0044-1787762
Investigation of the relationship between thrombophilic disorders and brain white matter lesions in migraine with aura[*]
Investigación de la relación entre los trastornos trombofílicos y las lesiones de la sustancia blanca cerebral en la migraña con auraAbstract
Background Migraine is associated with several genetic or acquired comorbidities. Studies conducted in recent years emphasize that the frequency of thrombophilia is high in migraine, especially migraine with aura (MA). Similarly, the presence of white matter lesions (WMLs) on brain magnetic resonance imaging (MRI) scans has been associated with migraine for many years.
Objective Based on the knowledge that both WMLs and thrombophilia variants are frequently observed in MA, we aimed to investigate whether there is a relationship between genetic thrombophilia and the presence of WMLs in these patients.
Methods The levels of proteins S and C, antithrombin III activities, activated protein C (APC) resistance, antiphospholipid immunoglobulin G/immunoglobulin M (IgG/IgM) and anticardiolipin IgG/IgM antibodies were investigated in 66 MA patients between the ages of 18 and 49 years who presented no cardiovascular risk factors. The presence of WMLs and the Fazekas grade was determined from the brain magnetic resonance imaging (MRI) scans' T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequence taken from the patients. The rates of WMLs were compared in patients with and without thrombophilia.
Results Thrombophilia was detected in 34.8% of the patients, and 27.3% were determined to have WMLs in brain MRI scans. The WMLs were detected in 23.3% of the patients without thrombophilia, in 34.8% of those with thrombophilia, and in 50% of the subjects with multiple thrombophilia disorders. Among the thrombophilia disorders, only APC resistance was significantly more common in patients with WMLs.
Conclusion The results of the present study showed that thrombophilia may be a mechanism that should be investigated in the etiology of increased WMLs in MA.
Resumen
Antecedentes La migraña se asocia con una serie de comorbilidades genéticas o adquiridas. Los estudios realizados en los últimos años destacan que la frecuencia de trombofilia es elevada en la migraña, especialmente en la migraña con aura (MA). De manera similar, la presencia de lesiones de la sustancia blanca (LSB) en las imágenes por resonancia magnética (RM) del cerebro se ha asociado con la migraña hace muchos años.
Objetivo Con base en la información de que se suelen observar tanto LSB como variantes de la trombofilia en MA, nuestro objetivo fue investigar si existe una relación entre la trombofilia genética y la presencia de LSB en estos pacientes.
Métodos Se investigaron los niveles de proteína S y de proteína C, actividades de antitrombina III, resistencia a la proteína C activada (PCA), anticuerpos antifosfolípidos inmunoglobulina G/inmunoglobulina M (IgG/IgM) y anticuerpos anticardiolipina IgG/IgM en 66 pacientes con MA entre 18 y 49 años que no presentaban factores de riesgo cardiovascular. Se determinaron la presencia de LSB y el grado de Fazekas a partir de imágenes por RM del cerebro en la secuencia ponderada en T2 y recuperación de la inversión atenuada de fluido (fluid-attenuated inversion recovery, FLAIR, en inglés) obtenidas de los pacientes. Se compararon las tasas de LSB en pacientes con y sin trombofilia.
Resultados Se detectó trombofilia en el 34,8% de los pacientes y LSB en el 27,3%. Las LSB estuvieron presentes en el 23,3% de los pacientes sin trombofilia, en el 34,8% de los que tenían trombofilia, y en el 50% de los que tenían múltiples trastornos trombofílicos. La resistencia a la PCA fue significativamente más común en aquellos pacientes con LSB.
Conclusión Los resultados del presente estudio mostraron que la trombofilia puede ser un mecanismo que debe investigarse en la etiología del aumento de LSB en MA.
* Part of this study was presented as a verbal presentation at the 57th National Neurology Congress, in 2021.
Publication History
Received: 14 February 2024
Accepted: 16 April 2024
Article published online:
08 July 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
Fatma Yılmaz Can. Investigation of the relationship between thrombophilic disorders and brain white matter lesions in migraine with aura[*] . Arq Neuropsiquiatr 2024; 82: s00441787762.
DOI: 10.1055/s-0044-1787762
-
References
- 1 Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache 2013; 53 (02) 230-246 DOI: 10.1111/head.12038.
- 2 Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. Cephalalgia 2013; 33 (05) 289-290 . Doi: 10.1186%2F1129-2377-14-1
- 3 Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders. 3rd edition. Cephalalgia 2018; 38 (01) 1-211 DOI: 10.1177/0333102417738202.
- 4 Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ 1995; 311 (7004): 541-544 . Doi: 10.1136%2Fbmj.311.7004.541
- 5 Cavestro C, Mandrino S. Thrombophilic disorders in migraine. Front Neurol 2014; 5: 120 . Doi: 10.3389%2Ffneur.2014.00120
- 6 Cavestro C, Degan D, Micca G. et al. Thrombophilic alterations, migraine, and vascular disease: results from a case-control study. Neurol Sci 2021; 42 (09) 3821-3828 DOI: 10.1007/s10072-020-05006-z.
- 7 Foy P, Moll S. Thrombophilia: 2009 update. Curr Treat Options Cardiovasc Med 2009; 11 (02) 114-128 DOI: 10.1007/s11936-009-0012-x.
- 8 Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients?. Br J Haematol 2008; 143 (03) 321-335 DOI: 10.1111/j.1365-2141.2008.07339.x.
- 9 Dautaj A, Krasi G, Bushati V. et al. Hereditary thrombophilia. Acta Biomed 2019; 90 (10-S, Suppl 10) 44-46 DOI: 10.23750/abm.v90i10-S.8758.
- 10 Bolaman Z. Aktive Protein C Direnci. XXIX. Ulusal Hematoloji Kongresi Mezuniyet Sonrası Eğitim Kursu. 2002 https://www.thd.org.tr/thdData/userfiles/file/aktive.pdf
- 11 D'Amico D, Moschiano F, Leone M. et al. Genetic abnormalities of the protein C system: shared risk factors in young adults with migraine with aura and with ischemic stroke?. Cephalalgia 1998; 18 (09) 618-621 , discussion 591 DOI: 10.1046/j.1468-2982.1998.1809618.x.
- 12 Al-Hashel JY, Alroughani R, Gad K, Al-Sarraf L, Ahmed SF. Risk factors of white matter hyperintensities in migraine patients. BMC Neurol 2022; 22 (01) 159 . Doi: 10.1186%2Fs12883-022-02680-8
- 13 Dobrynina LA, Suslina AD, Gubanova MV. et al. White matter hyperintensity in different migraine subtypes. Sci Rep 2021; 11 (01) 10881 . Doi: 10.1038%2Fs41598-021-90341-0
- 14 Negm M, Housseini AM, Abdelfatah M, Asran A. Relation between migraine pattern and white matter hyperintensities in brain magnetic resonance imaging. Egypt J Neurol Psychiat Neurosurg 2018; 54 (01) 24 . Doi: 10.1186%2Fs41983-018-0027-x
- 15 Maitrot-Mantelet L, Horellou MH, Massiou H, Conard J, Gompel A, Plu-Bureau G. Should women suffering from migraine with aura be screened for biological thrombophilia?: results from a cross-sectional French study. Thromb Res 2014; 133 (05) 714-718 DOI: 10.1016/j.thromres.2014.01.025.
- 16 Öntürk Akyüz H. Investigation of the Impact of Migraine Symptoms on Life Quality and Pain Intensity. Van Sag Bil Derg. 2021; 14 (02) 209-215 DOI: 10.1212/wnl.55.5.624.
- 17 García de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost 2007; 98 (03) 543-556
- 18 Tait RC, Walker ID, Reitsma PH. et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73 (01) 87-93
- 19 Wells PS, Blajchman MA, Henderson P. et al. Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study. Am J Hematol 1994; 45 (04) 321-324 DOI: 10.1002/ajh.2830450409.
- 20 Vurkun M, Vural Ö, Demir M. et al. The Prevalence of Activated Protein C Resistance and F V Leiden in Healthy Population of Edirne, Turkey. Turk J Haematol 2002; 19 (02) 287-291
- 21 Duarte-García A, Pham MM, Crowson CS. et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol 2019; 71 (09) 1545-1552 DOI: 10.1002/art.40901.
- 22 Dönmez-Demir B, Yemisci M, Kılıç K. et al. Microembolism of single cortical arterioles can induce spreading depression and ischemic injury; a potential trigger for migraine and related MRI lesions. Brain Res 2018; 1679: 84-90 DOI: 10.1016/j.brainres.2017.11.023.
- 23 Nozari A, Dilekoz E, Sukhotinsky I. et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010; 67 (02) 221-229 DOI: 10.1002/ana.21871.
- 24 Ferrara M, Capozzi L, Bertocco F, Ferrara D, Russo R. Thrombophilic gene mutations in children with migraine. Hematology 2012; 17 (02) 115-117 DOI: 10.1179/102453312X13221316478010.
- 25 Porter A, Gladstone JP, Dodick DW. Migraine and white matter hyperintensities. Curr Pain Headache Rep 2005; 9 (04) 289-293 DOI: 10.1007/s11916-005-0039-y.
- 26 Dinia L, Bonzano L, Albano B. et al. White matter lesions progression in migraine with aura: a clinical and MRI longitudinal study. J Neuroimaging 2013; 23 (01) 47-52 DOI: 10.1111/j.1552-6569.2011.00643.x.
- 27 Kruit MC, van Buchem MA, Hofman PAM. et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291 (04) 427-434 DOI: 10.1001/jama.291.4.427.
- 28 Nilsson B, Back V, Wei R, Plane F, Jurasz P, Bungard TJ. Potential Antimigraine Effects of Warfarin: An Exploration of Biological Mechanism with Survey of Patients. TH Open 2019; 3 (02) e180-e189 DOI: 10.1055/s-0039-1692989.
- 29 Wammes-van der Heijden EA, Tijssen CC, van't Hoff AR, Egberts AC. A thromboembolic predisposition and the effect of anticoagulants on migraine. Headache 2004; 44 (05) 399-402 DOI: 10.1111/j.1526-4610.2004.04090.x.
- 30 Alqifari S. Warfarin Therapy Improved Migraine Headaches with Aura: A Case Report. Arch Pharm Pract (Mumbai) 2023; 14 (01) 66-68 DOI: 10.51847/lXDZ0BFUJ7.
- 31 Hughes GR. Migraine, memory loss, and “multiple sclerosis ”. Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad Med J 2003; 79 (928) 81-83 . Doi: 10.1136%2Fpmj.79.928.81